Drug Clearance Calculator

Drug clearance (CL) and volume of distribution (Vd) are the two fundamental pharmacokinetic parameters that govern drug behaviour in the body. Together, they determine the elimination half-life, steady-state concentration, and appropriate dosing intervals for any drug following first-order kinetics. This calculator lets you explore the relationships between these parameters using the standard one-compartment pharmacokinetic model. You can calculate CL from Vd and half-life, or calculate steady-state plasma concentrations from dosing information. This is an educational tool for students and healthcare professionals learning pharmacokinetics. Clinical dosing decisions must involve qualified prescribers and pharmacists.

4.85 L/hr
12.89 mg/L
6.00 hr

Drug clearance pharmacokinetic equations

CL = (0.693 x Vd) / t1/2 (units: L/hr)
Steady-state average concentration: Css = (F x Dose) / (CL x Dosing interval)
t1/2 = (0.693 x Vd) / CL
Steady state reached after 4-5 half-lives of repeated dosing.

Drug clearance: frequently asked questions

What is drug clearance (CL)?

Drug clearance (CL) is the theoretical volume of blood from which a drug is completely removed per unit of time (units: mL/min or L/hr). Total body clearance is the sum of all elimination routes: renal clearance + hepatic clearance + other clearance. A higher clearance means the drug is eliminated more quickly. Clearance is the primary pharmacokinetic parameter that determines steady-state drug concentration: Css = Dose rate / CL.

What is volume of distribution (Vd)?

Volume of distribution (Vd) is not a real volume, but a theoretical volume that relates the total amount of drug in the body to its plasma concentration. Vd = Dose / C0, where C0 is the initial plasma concentration. A large Vd (greater than total body water, about 42 L for a 70 kg adult) means the drug distributes extensively into tissues. Highly lipophilic drugs like chloroquine can have Vd values of hundreds or thousands of litres.

How are CL and Vd related to half-life?

The relationship is: t1/2 = (0.693 x Vd) / CL. This shows that half-life is not an independent parameter - it is determined by both Vd and CL. A drug can have a long half-life either because it has a large Vd (distributes widely into tissues) or because it has a low clearance (eliminated slowly). Understanding CL and Vd separately is more informative than half-life alone for predicting drug behaviour.

How does renal impairment affect drug clearance?

For drugs primarily eliminated by the kidneys, renal impairment reduces clearance proportionally to the reduction in GFR. If a drug is 100% renally cleared and GFR falls by 50%, clearance also falls by 50%, doubling the half-life. This means the drug accumulates to higher steady-state concentrations at the same dose. The Cockcroft-Gault creatinine clearance formula is the standard used for dose adjustment in renal impairment for most drugs.

What is bioavailability and how does it affect drug levels?

Bioavailability (F) is the fraction of a dose that reaches the systemic circulation unchanged. Oral bioavailability is reduced by incomplete absorption and first-pass hepatic metabolism. Some drugs have very low bioavailability (e.g. morphine F = 30%, propranolol F = 26%) while others are nearly 100% (e.g. amoxicillin F = 95%). When calculating steady-state concentrations from oral dosing, the dose rate must be multiplied by F: Css = (F x Dose rate) / CL.

Official sources

Reviewed by the CalculatorHub team, edited by James Graham, 14 June 2026. See our methodology.